Malignant Liver Neoplasm — Trials

Malignant Liver Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

4,126 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 908
Recruiting: 530
Ph III recruiting: 46
Growth YoY: +5.9%
Industry share: 20%
Top sponsor: Sun Yat-sen University
Termination share: 32.5%
Trials / 1,000 deaths: 30.4 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (460)

clinicaltrialsPublishedShowing 251–257 of 257 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05678270	A Study of ICP-192 in Patients With FGFR2-Rearranged Unresectable or Metastatic Intrahepatic Cholangiocarcinoma	recruiting	Phase 2	70	Beijing InnoCare Pharma Tech Co., Ltd.INDUSTRY	1	Feb 7, 2024	clinicaltrials
NCT06244225	HAIC (Hepatic Artery Infusion Chemotherapy，HAIC）Plus Sintilimab and Donafenib in the First-line Treatment of Unresectable Hepatocellular Carcinoma	recruiting	Phase 2	38	Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER